Junior Editorial Board
Junior Editorial Board Members
Research Interests: medicinal chemistry, drug design, epigenetics, metal-based drugs, alkylating agents, tubulin-binding drugs, kinase inhibitors, HDAC inhibitors.
Research Interests: ovarian cancer, cell death, necroptosis, cancer stem cells, chemoresistance, metabolism, DNA damage and repair, ovary and brain.
Qian Chen
The Fourth People's Hospital Affiliated to Tongji University, Shanghai, China.
Research Interests: nanocatalysis, tumor therapy.
Research Interests: lung adenocarcinoma, non-small cell lung cancer, drug resistance, thoracic cancer.
Research Interests: cancer therapeutics, tumor microenvironment, cancer-associated fibroblasts, drug pharmacology, drug resistance.
Research Interests: glioma, nano-medicine, 3D Bioprinting, radio-and chemo-therapy resistance.
Dechao Feng
Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Research Interests: identifying prognostic biomarkers, big data multi-omics analysis, aging, immunology, nanomaterials, drug-related aspects of cancer rehabilitation.
Research Interests: autophagy, tumor microenvironment, cell metabolism, dormancy, nutraceutics, epigenetics, 3D models, personalized cancer therapy.
Research Interests: micelleplexes, polymeric micelles, nanomedicine, nanotechnology, gene therapy, cyclodextrins, mucoadhesive polymers.
Research Interests: triple negative breast cancer, DNA damage, DNA repair, base excision repair.
Gunnel Hallden
Barts and The London School of Medicine and Dentistry, London, UK.
Research Interests: virotherapy, oncolytic adenovirus, combination therapies, small molecule inhibitors, cancer cell biology, cancer resistance, prostate cancer, pancreatic cancer, in vivo studies.
Research Interests: circulating tumor cells (CTCs), liquid biopsy, cancer metastasis, non-invasive biomarkers.
Research Interests: cancer drug resistance, cancer biology, genomics, precision oncology.
Lipeng Hu
Shanghai Jiao Tong University Shanghai Cancer Institute, Shanghai, China.
Research Interests: metabolism reprogramming in tumor microenvironment including tumor cells, stromal cells, immune cells.
Research Interests: cancer biology, lung cancer, brain metastasis, chemotherapeutic resistance, cancer therapeutics, cancer metabolism, protein kinases, molecular biophysics, small molecule inhibitors, structure-based drug design and discovery.
Research Interests: chemoresistance, immunoresistance, cancer metabolism, stem cells, inflammation, ER stress, new cancer models, new therapeutic approaches.
Ke Li
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Research Interests: basic and clinical translational of Leukemia, malignant hematologic system tumors, breast cancer, and liver cancer.
Yuehua Li
The First Affiliated Hospital, University of South China, Hengyang, Hunan, China.
Research Interests: chest tumor, malignant tumor metastasis, drug resistance.
Xian Lin
Hong Kong University of Science and Technology Medical Center, Peking University, Shenzhen, China.
Research Interests: natural compounds, oncology, immunology, epigenetic modification, signal transduction, bioinformatics, non-coding RNA.
Xiaoxiao Liu
Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Research Interests: cancer immunology, gene immunotherapy, anticancer therapy, liver injury and inflammatory.
Alan P Lombard
Department of Urologic Surgery, Department of Biochemistry and Molecular Medicine, School of Medicine, UC Davis, USA.
Research Interests: prostate cancer, therapeutic resistance, treatment response, drug tolerant persistence, PARP inhibition, AR pathway inhibitors, precision medicine, rational combination therapy.
Research Interests: growth factor signaling, steroid receptor/coactivator signaling, the interplay between these two signaling pathways in cancer progression and metastasis.
Peng Luo
Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Research Interests: antitumor pharmacogenomics, tumor immune microenvironment.
Liying Ma
School of Pharmacy, Zhengzhou University, Zhengzhou, Henan, China.
Research Interests: targeted drug discovery and mechanism research.
Wei Ma
Jiangnan University, Wuxi, Jiangsu, China.
Research Interests: preparation of nano-biological probes; tumor marker detection and treatment.
Research Interests: cancer biology, cancer drug resistance, autophagy, apoptosis, translation modulation, single-cell analysis, multiple myeloma, breast cancer.
Wenjun Mao
The affiliated Wuxi people’s hospital of Nanjing Medical University, Wuxi, Jiangsu, China.
Research Interests: application of biomaterials in medical field, basic and clinical research of lung cancer, tumor exosomes, tumor immune microenvironment, tumor immunotherapy, tumor biology, bioinformatic.
Research Interests: high throughput drug screening (HTS), medulloblastoma, acute lymphoblastic leukemia, pediatric cancer, cell cycle, apoptosis, kinase inhibitors.
Research Interests: cancer, theragnostics, targeted therapy, nanotechnology, nanomedicine, multifunctional nanomaterials, nanocarriers, drug delivery.
Research Interests: lung cancer, epidermal growth factor receptor (EGFR), tyrosine kinase inhibitors (TKIs), structure-based drug design, TKIs resistance, non-small cell lung cancer.
Fu Peng
West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China.
Research Interests: oncology, tumor microenvironment, natural products, non-coding RNA, regulated cell death.
Research Interests: drug discovery, pancreatic cancer, lung cancer, cancer drug resistance, cancer therapy, cancer biology, extracellular vesicles.
Research Interests: cancer, targeted drug delivery, tumor microenvironment, cancer nanomedicine, biomimetic nanotechnology, biomaterials, drug resistance.
Research Interests: immunotherapy, prostate cancer, gastric cancer, renal cell carcinoma, chemotherapy.
Research Interests: oxidative stressors and lipid mediators, cancer pharmacology and chemoprevention, anti-cancer agents and immunomodulation, cellular signaling pathways in tumor resistance mechanisms.
Iris Chiara Salaroglio
Department of Oncology, University of Turin, Turin, Italy.
Research Interests: MDR, oncology, chemoresistance, immunoresistance, drug response.
Research Interests: molecular targeted therapy for lung cancer drug resistance, tumor metastasis, tumor pharmacology, tumor metabolism.
Tingyan Shi
Zhongshan Hospital, Fudan University, Shanghai, China.
Research Interests: cervical cancer, ovarian cancer, uterine fibroids, ovarian tumors.
Research Interests: targeted therapy, nanotherapy, multidrug resistance, drug delivery, combination therapy, prostate cancer, breast cancer, ovarian cancer.
Research Interests: tumor microenvironment, cancer immunotherapy, breast and lung cancer, tumor metastasis, non-coding RNAs, cancer stem cells and radioresistance.
Research Interests: regulated cell death, cancer drug resistance.
Research Interests: multidrug resistance, cancer pharmacology, molecular modeling, ABC transporters, drug repurposing, virtual drug screening.
Jingya Wang
Department of Cancer Center, Houston Methodist, Houston, TX, USA.
Research Interests: myltiple myeloma, epigenetics, immunotherapy, cancer immunology, gamma delta T cells, CAR-T.
Ling Wang
School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Research Interests: computer-aided drug design, artificial intelligence-aided drug discovery and medicinal chemistry, the design and discovery of kinase inhibitors.
Yumin Wang
Aerospace Center Hospital/Peking University Aerospace School of Clinical Medicine, Beijing, China.
Research Interests: regulated cell death and cancer drug resistance.
Zheng Wang
Comprehensive Breast Health Center, Ruijin Hospital and Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests: oncology, cancer metastasis, tumor microenvironment, breast cancer, immunotherapy, metabolic reprogramming, novel target, interventional strategy, clinical pattern, predictive model.
Research Interests: cancer drug resistance, small-molecule agents for cancer immunotherapy, intratumoral microbiota and drug interactions.
Wen Xiao
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China.
Research Interests: renal cancer, prostate cancer, bladder tumor, tumorigenesis.
Feifei Yang
Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Research Interests: tumor microenvironment, tumor initiation, tumor progression, mechanisms, translational research.
Research Interests: prostate cancer, cancer metabolism, metabolic imaging, metabolomics, diet & lipid metabolism, cancer microenvironment, resistance to endocrine therapies, cancer progression.
Research Interests: tumor biology, novel technology application in cancer research, anticancer agents from natural products.
Wei Zhao
Key Laboratory of Stem Cells and Tissue Engineering, Sun Yat-Sen University, Guangzhou, China.
Research Interests: cancer epigenetics, histone modification and RNA methylation in cancers, single-cell analysis of tumor environment.
Research Interests: natural products, cancer resistance, cancer biology, apoptosis, immunotherapy, exosomes, epigenetics.
Research Interests: the discovery of biomarkers, novel therapeutic strategies of immunotherapy and targeted therapy of lung cancer, including patients with rare thoracic cancers, such as pulmonary sarcomotoid carcinoma, pulmonary large cell neuroendocrine carcinoma, et al.